Skip to main content
. 2019 Feb 4;9(2):17. doi: 10.1038/s41408-019-0178-8

Fig. 3. Expression of FcRH5 receptors (CD307) and DFRF4539A engagement on plasma cells (CD45dim/CD38++/CD138+) in bone marrow aspirates.

Fig. 3

a Overlay of isotype control antibody (anti-Her2) and anti-FcRH5 antibody (clone 10A8, a competing and blocking antibody with respect to DFRF4539A) at baseline vs. post-dosing. b Overlay of isotype control antibody (anti-Her2) and anti-FcRH5 antibody (clone 7D11, a non-competing and non-blocking antibody with respect to DFRF4539A) at baseline vs. post-dosing